Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
FDA Voucher Program Approvals Will Come From Product Centers, But Ambiguity Lingers
Jan 22 2026
•
By
Sue Sutter
The signatory authority for CNPV product applications is not clear, experts said.
(Shutterstock)
Learn what's happening at the US FDA. On the go.
Derrick Gingery and the team bring you a weekly "Drug Fix".
More from Review Pathways
More from United States